| Dear E,
It's tough to stay current on the fast-changing field of novel therapies. This brand-new Advanced Therapies class on Nov. 15 in Boston will bring you up-to-date on the latest in innovative drugs currently in development or newly on the market.
In one day, you will learn:
- The rationale behind cancer immunotherapies
- The challenges and second-generation opportunities for immunotherapies
- The differentiation between the types of DNA- and RNA-based therapies
- The science driving gene therapy
- Multiple applications of genome editing
Who should attend?
This class is designed for those who work on the "business side" of life sciences so that they can more effectively communicate with those on the "science side." Many attendees work in: business development, finance, legal, marketing, research, quality assurance, regulatory affairs, manufacturing or just need to understand the science of the biopharma industry.
Don't wait - this course is limited to 28 attendees and will not be offered again this year!
| 
